Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 14, 2019 - Issue 2
Submit an article Journal homepage
2,069
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Challenges with risk mitigation in academic drug discovery: finding the best solution

Anuradha RoyHigh Throughput Screening laboratory, University of Kansas, Lawrence, KS, USACorrespondence[email protected]
View further author information
Pages 95-100 | Received 23 Sep 2018, Accepted 27 Nov 2018, Published online: 04 Dec 2018

References

  • Roy A. Early probe and drug discovery in academia: a minireview. High Throughput. 2018 Feb 9;7(1):4. PubMed PMID: 29485615; PubMed Central PMCID: PMC5876530. eng.
  • Palmer M, Chaguturu R. Academia-pharma partnerships for novel drug discovery: essential or nice to have? Expert Opin Drug Discov. 2017 Jun;12(6):537–540. PubMed PMID: 28394189; eng.
  • Austin CP, Brady LS, Insel TR, et al. NIH molecular libraries initiative. Science (New York, NY). 2004 Nov 12;306(5699):1138–1139. PubMed PMID: 15542455; eng.
  • Slusher BS, Conn PJ, Frye S, et al. Bringing together the academic drug discovery community. Nat Rev Drug Discov. 2013 Nov;12(11):811–812. PubMed PMID: 24172316; PubMed Central PMCID: PMCPMC4076044. eng.
  • Huryn DM, Resnick LO, Wipf P. Contributions of academic laboratories to the discovery and development of chemical biology tools. J Med Chem. 2013 Sep 26;56(18):7161–7176. PubMed PMID: 23672690; PubMed Central PMCID: PMCPMC3785552. eng.
  • Schreiber SL, Kotz JD, Li M, et al. Advancing biological understanding and therapeutics discovery with small-molecule probes. Cell. 2015 Jun 4;161(6):1252–1265. PubMed PMID: 26046436; PubMed Central PMCID: PMCPMC4564295. eng.
  • Workman P, Collins I. Probing the probes: fitness factors for small molecule tools. Chem Biol. 2010 Jun 25;17(6):561–577. PubMed PMID: 20609406; PubMed Central PMCID: PMCPMC2905514. eng.
  • What is the REF? [Internet]. 2017. [cited 2018 Nov 26]. Available from: https://www.ref.ac.uk/about/whatref/
  • Chevaillier T. Evaluation in French higher education: history, policy and debates. 2013. p. 8. [cited 2018 Nov 26]. Available from: www.scuolademocratica.it/en/wpcontent/uploads/2013/05/1_2013–Chevaillier.pdf
  • Turri M. The new Italian agency for the evaluation of the university system (ANVUR): a need for governance or legitimacy? Qual Higher Educ. 2014 Jan 2;20(1):64–82.
  • Peterson KR, Costa FC, Fedosyuk H, et al. A cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies. PLoS One. 2014;9(9):e107006. PubMed PMID: 25225870; PubMed Central PMCID: PMCPMC4165891. eng.
  • Frye SV, Arkin MR, Arrowsmith CH, et al. Tackling reproducibility in academic preclinical drug discovery [Comment]. Nat Rev Drug Discov. 2015;14:733.
  • Dolgin E. Drug discoverers chart path to tackling data irreproducibility. Nat Rev Drug Discov. 2014 Dec 1 online;13:875.
  • Baell JB, Nissink JWM. Seven year itch: Pan-Assay Interference Compounds (PAINS) in 2017—Utility and limitations. ACS Chem Biol. 2018 Jan 19;13(1):36–44.
  • Wyatt PG, Gilbert IH, Read KD, et al. Target validation: linking target and chemical properties to desired product profile. Curr Top Med Chem. 2011;11(10):1275–1283. PubMed PMID: 21401506; PubMed Central PMCID: PMCPMC3182078. eng.
  • Kyffin JA, Sharma P, Leedale J, et al. Impact of cell types and culture methods on the functionality of in vitro liver systems - A review of cell systems for hepatotoxicity assessment. Toxicol In Vitro. 2018 Apr;48:262–275. PubMed PMID: 29408671; eng.
  • Lai Y, Wei X, Lin S, et al. Current status and perspectives of patient-derived xenograft models in cancer research. J Hematol Oncol. 2017 May 12;10(1):106. PubMed PMID: 28499452; PubMed Central PMCID: PMCPMC5427553. eng.
  • Strovel J, Sittampalam S, Coussens NP, et al. Early drug discovery and development guidelines: for academic researchers, collaborators, and start-up companies. In: Sittampalam GS, Coussens NP, Brimacombe K, et al., editors. Assay guidance manual. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004:1–41
  • Huggett B, Paisner K. Top 20 translational researchers of 2017. Nat Biotechnol. 2018 Sep 6 online;36:798.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.